ÂÜÀòÂÒÂ×

Hans-Juergen is responsible for the company’s global research and development strategy including translational science, clinical development, regulatory affairs, market access, and medical affairs. The portfolios on which he and his teamwork span from pediatric allergies, to oncology, to obesity and diabetes, to inborn errors of metabolism, and more.

He is a board-certified physician and specialist in internal medicine and endocrinology holding an adjunct professorship at the University of Ulm, where he held student seminars in internal medicine, bedside teaching courses, and lectured on diabetes/metabolic syndrome and its complications. He has authored more than 200 publications in peer-reviewed scientific journals. With his experience in academic nutraceutical research and pharmaceutical drug development and more than 20 years in international healthcare, Hans-Juergen has progressed several preclinical molecules towards proof in humans and led eight new pharmaceutical products through international registration and launches.

With a dedication to fitness and sports, Hans-Juergen is passionate in his personal as well as professional life about the link between nutrition and good health.

Hans-Juergen earned his medical degree at Ludwig Maximilian University.